go back

Oklahoma rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $43,652 · 10th–90th $23,988–$851,1380%10%10th90th$43,652Professionalmedian $562,341 · 10th–90th $562,341–$676,0830%50%90th$562,341$20.0K$100.0K$500.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $602,559.59 / $851,138.04
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$22,387.21 / $34,673.69 / $57,543.99
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$501,187.23 / $724,435.96 / $1,023,292.99
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$977,237.22 / $977,237.22 / $977,237.22
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $851,138.04
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $549,540.87 / $575,439.94